DocCheck AG (XTER:AJ91) Debt-to-EBITDA : 0.70 (As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is DocCheck AG Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

DocCheck AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €0.00 Mil. DocCheck AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €5.74 Mil. DocCheck AG's annualized EBITDA for the quarter that ended in Jun. 2023 was €8.25 Mil. DocCheck AG's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 was 0.70.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for DocCheck AG's Debt-to-EBITDA or its related term are showing as below:

XTER:AJ91' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.01 Med: 0.03 Max: 0.53
Current: 0.49

During the past 13 years, the highest Debt-to-EBITDA Ratio of DocCheck AG was 0.53. The lowest was 0.01. And the median was 0.03.

XTER:AJ91's Debt-to-EBITDA is ranked better than
81.26% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 2.63 vs XTER:AJ91: 0.49

DocCheck AG Debt-to-EBITDA Historical Data

The historical data trend for DocCheck AG's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocCheck AG Debt-to-EBITDA Chart

DocCheck AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-EBITDA

Get a 7-Day Free Trial

0.04

0.36

0.10

0.35

0.53

DocCheck AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Debt-to-EBITDA	Get a 7-Day Free Trial															-	0.41	-	0.47	0.70

Competitive Comparison of DocCheck AG's Debt-to-EBITDA

For the Health Information Services subindustry, DocCheck AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DocCheck AG's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocCheck AG's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where DocCheck AG's Debt-to-EBITDA falls into.

DocCheck AG Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

DocCheck AG's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.913	+	6.161)	/	13.422
	=	0.53

DocCheck AG's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0	+	5.736)	/	8.248
	=	0.70

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Jun. 2023) EBITDA data.

DocCheck AG (XTER:AJ91) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

DocCheck AG Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of DocCheck AG's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

DocCheck AG (XTER:AJ91) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocCheck AG (XTER:AJ91) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

AJ91:Germany

Address

Doccheck AG, Vogelsanger Strac E 66, Koln, DEU, 50823

Website

http://www.doccheck.ag/investor

DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.

Executives

Dr. Frank Antwerpes

Board of Directors

DocCheck AG (XTER:AJ91) Headlines

No Headlines